Millipore and Novozymes produce animal-free cell culture supplements

Millipore has partnered with Novozymes to develop new animal-free cell culture supplements.

The new products, which will be used for biopharmaceutical manufacturing, will be sold under the brand name CellPrime.

Millipore will sell the products through its sales organisation, while Novozymes will manufacture them.

"Our expanded relationship with Novozymes broadens our commitment to develop a portfolio of high quality, animal-free alternatives that optimize productivity, address drug safety, and ease regulatory approval," said Andrew Bulpin, vice president of Millipore’s Upstream Bioprocessing Business Unit.

Peter Rosholm, vice president of Novozymes Biopharma, added that the involvement of both companies would accelerate the introduction of the product.

Cell culture supplements help mammalian cells produce the proteins that form the basis of biologic drugs.

According to Millipore, customers who seek animal free supplements have limited options.

The CellPrime products aim to reduce risk, ease regulator concerns and improve the consistency of industrial cell culture processes.

Millipore is a leading life sciences company, providing multi-disciplinary scientific expertise, tools and services for use within bioscience research and biopharmaceutical manufacturing.